Company Ticker News June 29, 2021Cybin Inc Biotech Co Reports $51 Million In Cash As Stifel Ups Price Target To $12 0 0 Share
Press Release June 29, 2021Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement 0 0 Share
Press Release June 29, 2021Cybin Inc. Releases Annual Financials and Provides Business Highlights 0 0 Share
Press Release June 24, 2021Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board 0 0 Share
Press Release June 22, 2021Cybin Announces Completion of its 51st Pre-Clinical Psychedelic Molecule Study 0 0 Share
Company Ticker News June 20, 2021Cybin to Present at the Emerging Growth Conference on June 23rd 0 0 Share
